Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.74 - $1.83 $102,301 - $252,988
138,245 Added 44.13%
451,542 $401,000
Q3 2022

Nov 14, 2022

BUY
$1.51 - $2.88 $617 - $1,177
409 Added 0.13%
313,297 $492,000
Q2 2022

Aug 15, 2022

SELL
$1.24 - $2.33 $29,774 - $55,947
-24,012 Reduced 7.13%
312,888 $629,000
Q3 2021

Nov 12, 2021

SELL
$7.41 - $10.99 $303,069 - $449,491
-40,900 Reduced 10.83%
336,900 $2.57 Million
Q2 2021

Aug 12, 2021

BUY
$6.35 - $10.0 $50,800 - $80,000
8,000 Added 2.16%
377,800 $3.66 Million
Q1 2021

May 17, 2021

SELL
$7.03 - $16.51 $151,145 - $354,965
-21,500 Reduced 5.49%
369,800 $3.06 Million
Q4 2020

Feb 03, 2021

BUY
$5.76 - $11.95 $441,216 - $915,370
76,600 Added 24.34%
391,300 $2.67 Million
Q3 2020

Nov 16, 2020

BUY
$6.17 - $18.82 $580,597 - $1.77 Million
94,100 Added 42.66%
314,700 $3.51 Million
Q2 2020

Aug 12, 2020

BUY
$1.73 - $6.76 $47,575 - $185,900
27,500 Added 14.24%
220,600 $1.39 Million
Q1 2020

May 06, 2020

BUY
$1.57 - $4.76 $27,789 - $84,252
17,700 Added 10.09%
193,100 $355,000
Q3 2019

Nov 12, 2019

BUY
$2.05 - $2.69 $52,274 - $68,595
25,500 Added 17.01%
175,400 $375,000
Q2 2019

Aug 14, 2019

BUY
$2.67 - $4.38 $8,811 - $14,454
3,300 Added 2.25%
149,900 $400,000
Q1 2019

May 13, 2019

BUY
$1.86 - $5.94 $62,496 - $199,584
33,600 Added 29.73%
146,600 $696,000
Q4 2018

Feb 11, 2019

BUY
$2.01 - $4.24 $49,043 - $103,456
24,400 Added 27.54%
113,000 $271,000
Q2 2018

Aug 03, 2018

BUY
$4.75 - $8.0 $420,850 - $708,800
88,600 New
88,600 $638,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.